Literature DB >> 25681099

Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis.

Philip Masson1, Angela C Webster2, Martin Hong3, Robin Turner1, Richard I Lindley4, Jonathan C Craig1.   

Abstract

BACKGROUND: People with chronic kidney disease (CKD) have an increased risk of stroke but the magnitude of increased risk and the independent effects of glomerular filtration rate (GFR) and albuminuria are unclear. We aimed to quantify the association between the independent and combined effects of GFR and albuminuria on stroke risk.
METHODS: We searched MEDLINE and EMBASE (February 2014) for cohort studies or randomized controlled trials (RCTs) which reported stroke incidence in adults with a baseline measurement of GFR and/or albuminuria. We extracted study and participant characteristics, risk of bias and relative risks (RR, with confidence interval; CI) of stroke associated with GFR and/or quantity of albuminuria, synthesized data using random effects meta-analysis and explored heterogeneity using meta-regression.
RESULTS: We identified 83 studies; 63 cohort studies (2 085 225 participants) and 20 RCTs (168 516 participants) reporting 30 392 strokes. There was an inverse linear relationship between GFR and risk of stroke, with risk of stroke increasing 7% (RR: 1.07, CI: 1.04-1.09) for every 10 mL/min/1.73 m(2) decrease in GFR. A 25 mg/mmol increase in albumin-creatinine ratio was associated with a 10% increased risk of stroke (RR: 1.10, 95% CI: 1.01-1.20). The effect of albuminuria was independent of GFR. Results were not different across subtypes of stroke, sex and varying prevalence of cardiovascular risk factors.
CONCLUSIONS: Stroke risk increases linearly and additively with declining GFR and increasing albuminuria. CKD staging may also be a useful clinical tool for identifying people who may benefit most from interventions to reduce cardiovascular risk.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  albuminuria; chronic kidney disease; glomerular filtration rate; stroke; systematic review

Mesh:

Year:  2015        PMID: 25681099     DOI: 10.1093/ndt/gfv009

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  62 in total

Review 1.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

3.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 4.  Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation.

Authors:  Samer Dahdaleh; Paresh Malhotra
Journal:  Curr Treat Options Neurol       Date:  2019-03-11       Impact factor: 3.598

5.  Chronic kidney disease referrals from general practitioners pre- and post National Institute for Health and Care Excellence guidance 2014.

Authors:  Aruna Arjunan; Mohammad S Jeelani; Sharon Docherty; Jo Taylor
Journal:  Clin Med (Lond)       Date:  2019-10-22       Impact factor: 2.659

6.  Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.

Authors:  Riccardo Proietti; Lucio Gonzini; Giovanni Pizzimenti; Antonietta Ledda; Pietro Sanna; Ahmed AlTurki; Vincenzo Russo; Mauro Lencioni
Journal:  Clin Cardiol       Date:  2018-12-04       Impact factor: 2.882

7.  Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Florian Lüders; Klaus Kaier; Gerrit Kaleschke; Katrin Gebauer; Matthias Meyborg; Nasser M Malyar; Eva Freisinger; Helmut Baumgartner; Holger Reinecke; Jochen Reinöhl
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-13       Impact factor: 8.237

Review 8.  Anticoagulation in CKD and ESRD.

Authors:  Kelvin Cheuk-Wai Leung; Jennifer Marie MacRae
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

Review 9.  Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

Authors:  Miho Kimachi; Toshi A Furukawa; Kimihiko Kimachi; Yoshihito Goto; Shingo Fukuma; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

10.  Is there a cardiovascular protective effect of aspirin in chronic kidney disease patients? A systematic review and meta-analysis.

Authors:  Bo Qu; Yuhua He; Lihua Wu; Hongmei Lu; Haili Wu; Mingquan Li
Journal:  Int Urol Nephrol       Date:  2019-12-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.